# Canopy Growth Corp (CGC)

Source page: https://stoqly.net/companies/cgc

- **Ticker:** CGC (Nasdaq)
- **Sector:** Health Care / Medicinal Chemicals & Botanical Products
- **SEC CIK:** 0001737927
- **Latest annual report:** 10-K filed 2026-06-15 (https://www.sec.gov/Archives/edgar/data/1737927/000119312526270260/cgc-20260331.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $0.65 on 2026-10-30 (−3.33% on the day)
- **Market cap:** $276M
- **EPS, trailing 12 months:** −$0.49
- **Revenue (FY2026):** $206M
- **Revenue growth:** +6.5%
- **Revenue growth, 5-year CAGR:** −13.0%
- **Gross margin:** 24.5%
- **Operating margin:** −56.8%
- **Net margin:** −92.4%
- **Free cash flow:** −$50.0M
- **Free cash flow margin:** −24.3%
- **Return on invested capital:** −22.7%
- **Return on equity:** −45.6%
- **Net debt:** −$85.2M
- **Change in share count:** +177.1%
- **Piotroski F-score:** 4/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.1M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/cgc/figures.csv

| US$ millions | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 61 | 170 | 413 | 379 | 252 | 220 | 193 | 206 |
| Operating income | -93 | -479 | -940 | -813 | -1,988 | -170 | -84 | -117 |
| Net income | -52 | -553 | -1,320 | -247 | -2,478 | -514 | -366 | -190 |
| Diluted EPS (US$) | -0.30 | -2.07 | -3.55 | -6.32 | -53.43 | -6.87 | -3.40 | -0.64 |
| Operating cash flow | -64 | -402 | -352 | -435 | -421 | -209 | -119 | -46 |
| Free cash flow | -201 | -886 | -477 | -465 | -428 | -212 | -127 | -50 |
| Cash | — | 1,387 | 1,824 | 1,096 | 571 | 150 | 92 | 262 |
| Debt and leases | — | 380 | 1,305 | 1,255 | 1,008 | 467 | 226 | 177 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.